VeriXiv
WHO preferred product characteristics for bivalent Salmonella Typhi/Paratyphi A vaccine for comprehensive protection against enteric fever– key considerations and research gaps
Publication
, Preprint
Ibarz Pavon, AB; Clemens, J; Craviotto, A; Crump, J; Garrett, D; Gordon, M; John, J; Keddy, K; Laurens, M; Liu, X; Marks, F; Pollard, A ...
2025
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Ibarz Pavon, A. B., Clemens, J., Craviotto, A., Crump, J., Garrett, D., Gordon, M., … Wilder-Smith, A. (2025). WHO preferred product characteristics for bivalent Salmonella Typhi/Paratyphi A vaccine for comprehensive protection against enteric fever– key considerations and research gaps. VeriXiv. https://doi.org/10.12688/verixiv.1752.1
Ibarz Pavon, Ana Belen, John Clemens, Alejandro Craviotto, John Crump, Denise Garrett, Melita Gordon, Jacob John, et al. “WHO preferred product characteristics for bivalent Salmonella Typhi/Paratyphi A vaccine for comprehensive protection against enteric fever– key considerations and research gaps.” VeriXiv, 2025. https://doi.org/10.12688/verixiv.1752.1.
Ibarz Pavon AB, Clemens J, Craviotto A, Crump J, Garrett D, Gordon M, et al. WHO preferred product characteristics for bivalent Salmonella Typhi/Paratyphi A vaccine for comprehensive protection against enteric fever– key considerations and research gaps. VeriXiv. 2025.
Ibarz Pavon, Ana Belen, et al. “WHO preferred product characteristics for bivalent Salmonella Typhi/Paratyphi A vaccine for comprehensive protection against enteric fever– key considerations and research gaps.” VeriXiv, 2025. Epmc, doi:10.12688/verixiv.1752.1.
Ibarz Pavon AB, Clemens J, Craviotto A, Crump J, Garrett D, Gordon M, John J, Keddy K, Laurens M, Liu X, Marks F, Pollard A, Saha S, Wilder-Smith A. WHO preferred product characteristics for bivalent Salmonella Typhi/Paratyphi A vaccine for comprehensive protection against enteric fever– key considerations and research gaps. VeriXiv. 2025.